UNIVERSITE D'AIX-MARSEILLE ;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) ;UNIVERSITE DE MONTPELLIER ;CENTRE HOSPITALIER UNIVERSITAIRE DE NIMES ;ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE
发明人:
BARDIN NATHALIE,BLOT-CHABAUD MARCEL,BOUVIER SYLVIE,LACROIX ODILE,DIGNAT-GEORGE FRANCOISE,GRIS JEAN-CHRISTOPHE RAYMOND
申请号：
US201615568097
公开号：
US2018164323(A1)
申请日:
2016.04.21
申请国别(地区):
美国
年份:
2018
代理人:
摘要：
The present invention relates to the field of human fertility treatment. The present invention more specifically relates to the identification of soluble CD146 (sCD146) as a biomarker which, when measured in an embryo culture medium, can be used to determine whether the embryo can be selected for implantation in the uterus of a mammal or not. The present invention thus provides a new tool and related kits to (pre)select embryo eligible for implantation. The invention also relates to methods for promoting pregnancy in a human who undergoes embryo transfer.
